Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution

Journal of Cellular Physiology

Volumn 226, Issue 5, 2011, Pages 1340-1352

  Shin, Dong Hui ^a   Jang, Si Hyong ^a   Kang, Byeong Cheol ^b   Kim, Hyun Jun ^a   Oh, Seung Hyun ^c   Kong, Gu ^a  

^a Hanyang University   (South Korea)

^b Seoul National University   (South Korea)

^c National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN 2; CYCLIN D1; FIBROBLAST GROWTH FACTOR 3; INHIBITOR OF DIFFERENTIATION 1; PROTEIN BAX; PROTEIN BCL 2; RETINOIC ACID RECEPTOR BETA; WNT PROTEIN;

ALVEOLOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BUDDING; CELL PROLIFERATION; CONTROLLED STUDY; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; INVOLUTION; MAMMARY GLAND; MORPHOLOGY; MOUSE; NONHUMAN; ORGANOGENESIS; PRECOCIOUS PUBERTY; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TERMINAL END BUD; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BETA CATENIN; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 2; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; EPITHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 3; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MAMMARY GLANDS, ANIMAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; POSTPARTUM PERIOD; PREGNANCY; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEXUAL MATURATION; SIGNAL TRANSDUCTION; UP-REGULATION; WNT PROTEINS;

MOUSE MAMMARY TUMOR VIRUS; MUS; MUS MUSCULUS;

EID: 79951783572     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22462     Document Type: Article

References (48)

1. Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA, Munger K. 1999. Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc Natl Acad Sci USA 96: 9637-9641.
2. Allred DC, Harvey JM, Berardo M, Clark GM. 1998. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11: 155-168.
3. Arendt LM, Rose-Hellekant TA, Sandgren EP, Schuler LA. 2006. Prolactin potentiates transforming growth factor alpha induction of mammary neoplasia in transgenic mice. Am J Pathol 168: 1365-1374.
4. Bagheri-Yarmand R, Talukder AH, Wang RA, Vadlamudi RK, Kumar R. 2004. Metastasis-associated protein 1 deregulation causes inappropriate mammary gland development and tumorigenesis. Development 131: 3469-3479.
5. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. 1990. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell 61: 49-59.
6. Cheung HW, Ling MT, Tsao SW, Wong YC, Wang X. 2004. Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells. Carcinogenesis 25: 881-887.
7. Clarkson RW, Wayland MT, Lee J, Freeman T, Watson CJ. 2004. Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 6: R92-R109.
8. Coppe JP, Itahana Y, Moore DH, Bennington JL, Desprez PY. 2004. Id-1 and Id-2 proteins as molecular markers for human prostate cancer progression. Clin Cancer Res 10: 2044-2051.
9. Fong S, Itahana Y, Sumida T, Singh J, Coppe JP, Liu Y, Richards PC, Bennington JL, Lee NM, Debs RJ, Desprez PY. 2003. Id-1 as a molecular target in therapy for breast cancer cell invasion and metastasis. Proc Natl Acad Sci USA 100: 13543-13548.
10. Gat U, DasGupta R, Degenstein L, Fuchs E. 1998. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell 95: 605-614.
11. Hara E, Yamaguchi T, Nojima H, Ide T, Campisi J, Okayama H, Oda K. 1994. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem 269: 2139-2145.
12. Harada N, Tamai Y, Ishikawa T, Sauer B, Takaku K, Oshima M, Taketo MM. 1999. Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J 18: 5931-5942.
13. Hatsell S, Rowlands T, Hiremath M, Cowin P. 2003. Beta-catenin and Tcfs in mammary development and cancer. J Mammary Gland Biol Neoplasia 8: 145-158.
14. Hussein SM, Duff EK, Sirard C. 2003. Smad4 and beta-catenin co-activators functionally interact with lymphoid-enhancing factor to regulate graded expression of Msx2. J Biol Chem 278: 48805-48814.
15. Imbert A, Eelkema R, Jordan S, Feiner H, Cowin P. 2001. Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol 153: 555-568.
16. Israel MA, Hernandez MC, Florio M, Andres-Barquin PJ, Mantani A, Carter JH, Julin CM. 1999. Id gene expression as a key mediator of tumor cell biology. Cancer Res 59: 1726s-1730s.
17. Jang KS, Han HX, Paik SS, Brown PH, Kong G. 2006a. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer. Cancer Lett 244: 203-210.
18. Jang TJ, Jung KH, Choi EA. 2006b. Id-1 gene downregulation by sulindac sulfide and its upregulation during tumor development in gastric cancer. Int J Cancer 118: 1356-1363.
19. Katoh M. 2006. Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther 5: 1059-1064.
20. Kebebew E, Treseler PA, Duh QY, Clark OH. 2000. The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer. Surgery 128: 952-957.
21. Kim H, Chung H, Kim HJ, Lee JY, Oh MY, Kim Y, Kong G. 2008. Id-1 regulates Bcl-2 and Bax expression through p53 and NF-kappaB in MCF-7 breast cancer cells. Breast Cancer Res Treat 112: 287-296.
22. Lane TF, Leder P. 1997. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice. Oncogene 15: 2133-2144.
23. Lee TK, Man K, Ling MT, Wang XH, Wong YC, Lo CM, Poon RT, Ng IO, Fan ST. 2003. Over-expression of Id-1 induces cell proliferation in hepatocellular carcinoma through inactivation of p16INK4a/RB pathway. Carcinogenesis 24: 1729-1736.
24. Lee JY, Kang MB, Jang SH, Qian T, Kim HJ, Kim CH, Kim Y, Kong G. 2009. Id-1 activates Akt-mediated Wnt signaling and p27(Kip1) phosphorylation through PTEN inhibition. Oncogene 28: 824-831.
25. Li B, Cheung PY, Wang X, Tsao SW, Ling MT, Wong YC, Cheung AL. 2007a. Id-1 activation of PI3K/Akt/NFkappaB signaling pathway and its significance in promoting survival of esophageal cancer cells. Carcinogenesis 28: 2313-2320.
26. Li X, Zhang Z, Xin D, Chua CW, Wong YC, Leung SC, Na Y, Wang X. 2007b. Prognostic significance of Id-1 and its association with EGFR in renal cell cancer. Histopathology 50: 484-490.
27. Lin CQ, Parrinello S, Campisi J, Desprez PY. 1999. Regulation of mammary epithelial cell phenotypes by the helix-loop-helix protein, Id-1. Endocr Relat Cancer 6: 49-50.
28. Lin CQ, Singh J, Murata K, Itahana Y, Parrinello S, Liang SH, Gillett CE, Campisi J, Desprez PY. 2000. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells. Cancer Res 60: 1332-1340.
29. Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW, Wong YC. 2003. Id-1 expression promotes cell survival through activation of NF-kappaB signalling pathway in prostate cancer cells. Oncogene 22: 4498-4508.
30. Ling MT, Lau TC, Zhou C, Chua CW, Kwok WK, Wang Q, Wang X, Wong YC. 2005. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis 26: 1668-1676.
31. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K, Benezra R. 1999. Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401: 670-677.
32. Matsuda Y, Yamagiwa S, Takamura M, Honda Y, Ishimoto Y, Ichida T, Aoyagi Y. 2005. Overexpressed Id-1 is associated with a high risk of hepatocellular carcinoma development in patients with cirrhosis without transcriptional repression of p16. Cancer 104: 1037-1044.
33. Nieto AI, Shyamala G, Galvez JJ, Thordarson G, Wakefield LM, Cardiff RD. 2003. Persistent mammary hyperplasia in FVB/N mice. Comp Med 53: 433-438.
34. Parrinello S, Lin CQ, Murata K, Itahana Y, Singh J, Krtolica A, Campisi J, Desprez PY. 2001. Id-1, ITF-2, and Id-2 comprise a network of helix-loop-helix proteins that regulate mammary epithelial cell proliferation, differentiation, and apoptosis. J Biol Chem 276: 39213-39219.
35. Phippard DJ, Weber-Hall SJ, Sharpe PT, Naylor MS, Jayatalake H, Maas R, Woo I, Roberts-Clark D, Francis-West PH, Liu YH, Maxson R, Hill RE, Dale TC. 1996. Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development. Development 122: 2729-2737.
36. Richert MM, Schwertfeger KL, Ryder JW, Anderson SM. 2000. An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 5: 227-241.
37. Roarty K, Serra R. 2007. Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth. Development 134: 3929-3939.
38. Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, Rudas M, Gnant M, Jakesz R, Birner P. 2003. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int J Cancer 104: 677-682.
39. Schorr K, Li M, Bar-Peled U, Lewis A, Heredia A, Lewis B, Knudson CM, Korsmeyer SJ, Jager R, Weiher H, Furth PA. 1999. Gain of Bcl-2 is more potent than bax loss in regulating mammary epithelial cell survival in vivo. Cancer Res 59: 2541-2545.
40. Singh J, Itahana Y, Parrinello S, Murata K, Desprez PY. 2001. Molecular cloning and characterization of a zinc finger protein involved in Id-1-stimulated mammary epithelial cell growth. J Biol Chem 276: 11852-11858.
41. Stein T, Salomonis N, Gusterson BA. 2007. Mammary gland involution as a multi-step process. J Mammary Gland Biol Neoplasia 12: 25-35.
42. Vivanco I, Sawyers CL. 2002. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501.
43. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A, Schmidt EV. 1994. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669-671.
44. Wang YA, Shen K, Wang Y, Brooks SC. 2005. Retinoic acid signaling is required for proper morphogenesis of mammary gland. Dev Dyn 234: 892-899.
45. Wong YC, Zhang XM, Ling MT, Wang XH. 2008. Inactivation of ID-1 gene induces sensitivity of prostate cancer cells to chemotherapeutic drugs. Adv Exp Med Biol 617: 565-572.
46. Zhang X, Ling MT, Wang X, Wong YC. 2006. Inactivation of Id-1 in prostate cancer cells: A potential therapeutic target in inducing chemosensitization to taxol through activation of JNK pathway. Int J Cancer 118: 2072-2081.
47. Zhang X, Ling MT, Wang Q, Lau CK, Leung SC, Lee TK, Cheung AL, Wong YC, Wang X. 2007a. Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells. J Biol Chem 282: 33284-33294.
48. Zhang X, Ling MT, Wong YC, Wang X. 2007b. Evidence of a novel antiapoptotic factor: Role of inhibitor of differentiation or DNA binding (Id-1) in anticancer drug-induced apoptosis. Cancer Sci 98: 308-314.